Cytomegalovirus viremia in lung transplantation during and after prophylaxis.
Andrew ChangMichael MuskMelanie LavenderJeremy WrobelMeow-Chong YawSharon LawrenceShiji ChirayathPeter A BoanPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2019)
Prophylaxis for 6 months in D+R+ and D-R+, and past 12 months in D+R- LTs, with long-term monitoring in all patients using a sensitive assay, and reinstitution of valganciclovir for low-level viremia was effective at markedly reducing the incidence of CMV disease. CMV D-R- LTs do not need routine CMV monitoring.